Kayla Fourzali (K Fourzali, K M Fourzali)

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Monoclonal Antibody

Top Venues

Expert opinion on drug safety

Journal of the European Academy of Dermatology and Venereology : JEADV

Expert opinion on emerging drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Kayla Fourzali, Rachel Shireen Golpanian, Gil Yosipovitch
Emerging drugs for the treatment of chronic pruritic diseases. Expert opinion on emerging drugs 25 (3) (2020)
Kayla Fourzali, Golpanian Rachel Shireen, Gil Yosipovitch
Dupilumab use in atopic dermatitis and beyond in skin diseases. Immunotherapy 12 (17) (2020)
Kayla Fourzali, Gil Yosipovitch
Genodermatoses with itch as a prominent feature. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (4) (2020)
Kayla Fourzali, Gil Yosipovitch
Safety considerations when using drugs to treat pruritus. Expert opinion on drug safety 19 (4) (2020)
Kayla Fourzali, R S Golpanian, Y H Chan, G Yosipovitch
Average daily itch vs. worst daily itch in chronic itch evaluation. The British journal of dermatology 183 (5) (2020)